Yuli Qian, PhD (he/him/his)

Associate Director, Clinical Pharmacology
AbbVie

Dr. Yuli Qian, PhD, is currently an Associate Director in Clinical Pharmacology at AbbVie Inc. He received his PhD in Clinical Pharmaceutical Sciences from the University of Florida, where his research focused on evaluating pharmacokinetic interactions between cannabis products and conventional medications. He joined AbbVie as a clinical pharmacologist in 2021, and currently serves as the clinical pharmacology lead for multiple immunology assets. In this role, he is responsible for conceiving and executing clinical pharmacology strategies and pharmacokinetic/pharmacodynamic analyses to inform dose selection decisions. He has supported multiple regulatory interactions and submissions. He also conducts due-deligence review of external assets for in-licensing opportunities.
Dr. Qian has been a member of ASCPT since 2022 and currently serves as a steering committee member of the Drug Utilization & Outcomes community at ASCPT.

Presentation(s):

• Pediatric Extrapolation: Unlocking the Clinical Pharmacology Toolbox to Accelerate Drug Access for Our Little Patients

  Friday, May 30, 2025
  1:30 PM - 2:30 PM East Coast USA Time